药物相关性血管病变的影像学研究。

IF 1.3 4区医学 Q4 NEUROIMAGING Neuroimaging Clinics of North America Pub Date : 2023-10-10 DOI:10.1016/j.nic.2023.07.003

Paulo Puac-Polanco MD, MSc , Àlex Rovira MD , Lubdha M. Shah MD , Richard H. Wiggins MD , Francisco Rivas Rodriguez MD , Carlos Torres MD, FRCPC, FCAR

引用次数: 0

摘要

非法和娱乐性药物，如可卡因、海洛因、安非他明和大麻，可导致与药物相关的血管炎或血管病变。同样，出于治疗目的而使用某些抗甲状腺、肿瘤和免疫抑制药物可导致血管病变。这反过来可能导致中枢神经系统的严重并发症，包括颅内出血和中风。可卡因滥用也会导致中线鼻窦复合体的破坏性损伤。MR成像、血管壁成像和CT/CTA是评估疑似药物性血管病变或血管炎患者的宝贵成像工具。本文综述了与药物滥用和处方药相关的血管病变的发病机制、临床表现和影像学表现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Imaging of Drug-Related Vasculopathy

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Neuroimaging Clinics of North America 医学-核医学

CiteScore

4.10

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Published four times a year—February, May, August, and November—Neuroimaging Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in neuroimaging and is presented under the direction of an experienced editor. Topics include brain and spine, head and neck, vascular, nerves, pediatric, movement disorders, and dementia. In addition, you can also purchase a CME subscription that offers up to 60 AMA Category 1 credits per year.

期刊最新文献

Contents The Subarachnoid Space: Percutaneous Access for Diagnosis and Image-Guided Therapies Copyright CME Accreditation Page Forthcoming Issues